Extracorporeal Shock Wave Therapy (ESWT) in the management of Decubitus ulceration in complex neurological disabilities

Completed

• Conditions: Skin and Connective Tissue Diseases: Decubitus ulceration; Skin and Connective Tissue Diseases; Decubitus ulceration

• Registration Number: ISRCTN88965832
• Lead Sponsor: Record Provided by the NHSTCT Register - 2007 Update - Department of Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-09-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 36

Inclusion Criteria

All patients in the Royal Hospital for Neuro-disability with decubitus ulceration who do not have exclusion criteria will be included in the study irrespective of age, level of disability or diagnosis.
The total number of patients at the Royal Hospital available for the study is expected to be 36.

Exclusion Criteria

1. Those patients who decline to receive treatment after the treatment has been explained to them
2. Those with bleeding disorders or who are on anticoagulant therapy
3. Decubitus ulceration of the chest wall (theoretical risk of lung damage from ESWT)
4. Decubitus ulceration of elbows and elbow creases (uncommon and difficult to access)
5. Ulceration of the ear (uncommon, difficult to access, risk of damage to brain)
6. Over a tumor site

Study & Design

• Study Type: Interventional
• Study Design: Not specified